Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen

Hiroshi Kishikawa, Kayoko Hukuhara, Asako Ito, Kyoko Arahata, Sakiko Takarabe, Shogo Kaida, Jun Miyauchi, Soichiro Miura, Jiro Nishida

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

RESULTS: Ten gastric neoplasia cases (gastric cancer and adenoma) were found to be included. Multiple logistic regression analyses identified H. pylori antibody titer ≥3 U/ml (odds ratio=14.4, 95% confidence interval=2.7-76.9; p<0.01) and pepsinogen-I/II ratio ≤4.3 ng/ml (odds ratio=10.0, 95% confidence interval=2.1-47.9; p<0.01), but not age as independent predictive factors of neoplasia.

CONCLUSION: Endoscopy should be considered in individuals with H. pylori antibody titer of ≥3 U/ml and a pepsinogen-I/II ratio of ≤4.3 in those classed as group A by ABC method.

BACKGROUND/AIM: Individuals negative for Helicbacter pylori antibody and with a normal pepsinogen test (group A) are regarded as being at low risk in serum gastric cancer screening known as the ABC method, and endoscopy is not recommended; however, this group may include 2-10% of gastric cancer cases.

PATIENTS AND METHODS: A total of 345 individuals who underwent upper gastrointestinal endoscopy and were classified by ABC as group A (H. pylori antibody titer <10 U/ml, and pepsinogen-I >70 ng/ml or I/II ratio >3) were enrolled, and predictors of gastric neoplasia were investigated.

Original languageEnglish
Pages (from-to)6765-6771
Number of pages7
JournalAnticancer Research
Volume35
Issue number12
Publication statusPublished - 2015 Dec 1
Externally publishedYes

    Fingerprint

Keywords

  • ABC method
  • Gastric cancer
  • Helicobacter pylori
  • pepsinogen
  • screening

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kishikawa, H., Hukuhara, K., Ito, A., Arahata, K., Takarabe, S., Kaida, S., Miyauchi, J., Miura, S., & Nishida, J. (2015). Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen. Anticancer Research, 35(12), 6765-6771.